What is the Historical Analysis of the Nucleic Acid Labeling Market Size?
The nucleic acid labeling market has seen considerable growth due to a variety of factors.
•In the past few years, the market size of nucleic acid labeling has seen substantial growth. The market is forecasted to expand from $2.56 billion in 2024 to $2.77 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%.
The growth seen in the historic period is due to factors such as elevated spending on healthcare, a rise in research and development expenditures, an increase in genomics research and disease diagnosis activity, a surge in the demand for personalized medicine, and the expansion of healthcare infrastructure.
What is the Forecasted Growth of the Nucleic Acid Labeling Market Size?
The nucleic acid labeling market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the nucleic acid labeling market is anticipated to witness robust growth, reaching $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 9.7%.
This growth in the forecasted period can be ascribed to increasing health consciousness among the population, the expanding influence of key international players, the emphasis on patient-oriented strategies, the burgeoning biotechnology industry, and the rising employment of dna sequencing. The forecast period will likely see significant trends such as the progression of devices for synthetic biology, advanced labeling methods, the creation of unique labeling techniques, innovative fluorescent dyes, and the incorporation of new labeling technologies in research and medical treatment.
What Key Factors and Trends are Driving the Growth of the Nucleic Acid Labeling Market?
The growth of the nucleic acid labeling market is purported to be driven by the increase in infectious diseases. Infectious diseases result from microorganisms such as parasites, bacteria, fungi, and viruses that can be transmitted directly or indirectly among people. Nucleic acid labeling techniques provide enhanced sensitivity, specificity, automation, visualization, real-time monitoring, and multiplexing ability for detecting contagious illnesses like tuberculosis, hepatitis, and gonorrhea. For example, the Centers for Disease Control and Prevention, a national public health organization in the US, reported in March 2023 that the United States saw an increase from 7,874 tuberculosis (TB) cases in 2021 to 8,300 reported cases in 2022. Additionally, the incidence rate for tuberculosis (TB) saw a slight increase in 2022 with 2.5 incidents per 100,000 residents. Consequently, the surge in infectious diseases is fueling the growth of the nucleic acid labeling market.
What are the Market Segments in the Nucleic Acid Labeling Market?
The nucleic acid labeling market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels, Non-Radioactive Labels
3) By Method: Enzyme-Based, Chemical-Based
4) By Application: DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications
5) By End User: Hospitals Or Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Kits: DNA Labeling Kits, RNA Labeling Kits, Multiplex Labeling Kits
2) By Reagents: Labeling Reagents, Buffer Solutions, Conjugation Reagents
3) By Instruments: Nucleic Acid Analyzers, Microarray Processors, Imaging Systems
Pre-Book The Nucleic Acid Labeling Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Nucleic Acid Labeling Market?
In the nucleic acid labeling market, technological innovations are emerging as a noteworthy trend. Leading businesses in this market are concentrating their efforts on making strides in nanotechnology to maintain their market stance. For example, Cambridge Nucleomics, a British biotech firm, pioneered a novel technology called nano bait in January 2023. This technology, which is employed for highly multiplexed detection of nucleic acid signatures resulting from respiratory pathogens, offers a more rapid solution for detecting viral RNA relative to other methodologies.
Who Are the Key Players in the Nucleic Acid Labeling Market?
Major companies operating in the nucleic acid labeling market include:
• General Electric Company
• F. Hoffman-La Roche AG
• Thermo Fisher Scientific Inc.
• Merck Group
• Roche Diagnostics Corporation
• GE Healthcare Bio Sciences AB
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Cytiva
• Qiagen N.V.
• Biotium Inc.
• Illumina Inc.
• LGC Group
• Promega Corporation
• New England Biolabs
• Enzo Biochem Inc.
• LI-COR Biosciences Inc.
• Eurogentec S.A.
• OriGene Technologies Inc.
• BaseClear B.V.
• Vector Laboratories Inc.
• Bio-Synthesis Inc.
• BioCat GmbH
• Jena Bioscience GmbH
• LubioScience GmbH
• GeneCopoeia Inc.
• Mirus Bio LLC
• Daicel Arbor Biosciences.
What are the Regional Insights into the Nucleic Acid Labeling Market?
North America was the largest region in the nucleic acid labeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
